Sarepta Therapeutics, Inc. — Director's Dealing 2017

Apr 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2017-04-20

Reporting Person: Kaye Edward M. MD (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-20	Common Stock	F	4349	$32.54	Disposed	66820	Direct

Footnotes

F1: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.